VIRI
-
- (-%)
- · NASDAQ
- Sector -
- Industry -
- Website virios.com
- Employees(FY) 4
- ISIN -
Performance
-
1W
-
1M
-
3M
-
6M
-
YTD
-
1Y
Profile
Virios Therapeutics, Inc., a development-stage biotechnology company, focuses on developing novel antiviral therapies to treat diseases associated with a viral triggered abnormal immune response. The company's lead development candidate is the IMC-1, a fixed dose combination of famciclovir and celecoxib to treat fibromyalgia. It also develops IMC-2, a combination of valacyclovir and celecoxib for the treatment of managing the fatigue, sleep, attention, pain, autonomic function, and anxiety associated with long COVID. The company was formerly known as Innovative Med Concepts, LLC and changed its name to Virios Therapeutics, Inc. in July 2020. Virios Therapeutics, Inc. was founded in 2012 and is headquartered in Alpharetta, Georgia.
Technical Analysis of VIRI 2024-10-09
Technical Scores and Rating
Moving Average Score
Oscillator Score
Technical Rating
Recent News & Updates
- 2024-10-07 20:29
Virios Therapeutics Transforms into Dogwood Therapeutics(Yahoo Finance)
- 2024-10-06 19:05
- 2024-08-07 21:15
- 2024-07-31 21:41
- 2024-07-22 21:15
- 2024-05-22 01:30
- 2024-05-20 02:19
Top Midday Decliners(Yahoo Finance)
- 2024-05-19 22:25
- 2024-05-19 21:20
Why Is Virios Therapeutics (VIRI) Stock Down 44% Today?(Investorplace)
- 2024-05-19 19:36
- 2024-05-19 15:54
- 2024-05-19 08:53
- 2024-05-17 04:10
- 2024-05-12 22:49
- 2024-05-08 19:45
- 2024-05-01 21:15
- 2024-03-25 21:15
- 2024-02-28 20:15
- 2024-02-27 20:15
- 2024-01-21 20:00
- 2024-01-01 18:05
- 2023-11-13 20:55
- 2023-11-12 18:05
- 2023-11-05 18:05
- 2023-10-11 19:05
- 2023-09-17 19:05
- 2023-09-11 19:05
- 2023-08-14 19:48
- 2023-08-13 19:05
- 2023-08-11 21:40
Page 1 of 4
previousnext
Disclaimer: The information provided here and on kavout.com site is for general informational purposes only. It does not constitute investment advice, financial advice, trading advice, or any other sort of advice. Kavout does not recommend that any investment decision be made based on this information. You are solely responsible for your own investment decisions. Please conduct your own research and consult with qualified financial advisors before making any investment. Kavout and its partners are participants in a number of affiliate advertising programs. As an Amazon Associate, Kavout or its partners earn from qualifying purchases from affiliate links. We also participate in other affiliate and advertising programs that provide a means for us to earn advertising fees by advertising and linking to third-party websites.